300363.SZ
博腾股份
SZSE · Healthcare · C 制造业 · CN
CNY 20.46
−6.53%Year over year
Reported trailing growth
- Revenue
- +11.8%
- EBITDA
- —
- EBIT
- +158.6%
- EPS
- +165.4%
- Free cash flow
- +4732.5%
- Operating cash flow
- +64.5%
Forward estimates
Based on analyst estimates
- Revenue
- +5.8%
- EBITDA
- +317.4%
- EPS
- +1018.5%
Three-year CAGR
- Revenue
- -21.4%
- EBITDA
- -41.6%
- EBIT
- -65.5%
- Net income
- -63.6%
- EPS
- -63.5%
- Free cash flow
- -30.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026